Page last updated: 2024-08-25

chitosan and Pulmonary Aspergillosis

chitosan has been researched along with Pulmonary Aspergillosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Burrow, AJ; Dennison, SR; Gorki, V; Katare, OP; Kaur, R; Kaushik, A; Rudramurthy, SM; Singh, B; Singh, KK; Swami, R	1

Other Studies

1 other study(ies) available for chitosan and Pulmonary Aspergillosis

Article	Year
Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention. Journal of nanobiotechnology, 2021, Jan-11, Volume: 19, Issue:1 Topics: A549 Cells; Administration, Inhalation; Animals; Antifungal Agents; Cell Survival; Chitosan; Clathrin; Drug Carriers; Drug Delivery Systems; Humans; Lipids; Lung; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polymers; Pulmonary Aspergillosis; Voriconazole	2021

Article

Year

Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention.

Journal of nanobiotechnology, 2021, Jan-11, Volume: 19, Issue:1

Topics: A549 Cells; Administration, Inhalation; Animals; Antifungal Agents; Cell Survival; Chitosan; Clathrin; Drug Carriers; Drug Delivery Systems; Humans; Lipids; Lung; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polymers; Pulmonary Aspergillosis; Voriconazole

2021